(2020-2030) Antisense & RNAi Therapeutics Market Size, Share, Growth And Trends - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

(2020-2030) Antisense & RNAi Therapeutics Market Size, Share, Growth And Trends

Description:

The major players covered in the global antisense & RNAi therapeutics market are Alnylam Pharmaceuticals, Benitec Biopharma Ltd., Gene Signal, GlaxoSmithKline Plc, Ionis Pharmaceuticals, Marina Biosciences, – PowerPoint PPT presentation

Number of Views:6
Date added: 11 September 2020
Slides: 7
Provided by: ramtbrc
Category: Other

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: (2020-2030) Antisense & RNAi Therapeutics Market Size, Share, Growth And Trends


1
Antisense RNAi Therapeutics Market Global
Report 2020-30 Covid 19 Growth And Change
2
Antisense RNAi Therapeutics Market
Characteristics
  • The global antisense RNAi therapeutics market is
    expected to decline from 1.14 billion in 2019 to
    1.11 billion in 2020 at a compound annual growth
    rate (CAGR) of -2.89. The decline is mainly due
    to the COVID-19 outbreak that has led to
    restrictive containment measures involving social
    distancing, remote working, and the closure of
    industries and other commercial activities
    resulting in operational challenges. The entire
    supply chain has been disrupted, impacting the
    market negatively. The market is then expected to
    recover and reach 1.44 billion in 2023 at a CAGR
    of 9.23.
  • The Business Research Company published its
    Antisense RNAi Therapeutics Global Market
    Report 2020 which provides strategists, marketers
    and senior management with the critical
    information they need to assess the global
    Antisense RNAi Therapeutics market. The report
    provides in-depth analysis of the impact of
    COVID-19 on the market, along with revised market
    numbers due to the effects of the coronavirus.
  • The report covers the Antisense RNAi
    Therapeutics markets segments-
  • 1) By Technology RNA Interference, Antisense RNA
  • 2) By Route of Administration Pulmonary
    Delivery, Intravenous Injections, Intra-dermal
    Injections, Intraperitoneal Injections, Topical
    Delivery, Other Delivery Methods
  • The major regions included in the report are
    Asia-Pacific, Western Europe, Eastern Europe,
    North America, South America, Middle East, and
    Africa.

Click Here To View Complete Report
3
Major Key PlayersAlnylam
Pharmaceuticals, Gene Signal, Ionis
Pharmaceuticals, Marina Biosciences, Quark
Pharmaceuticals,Sanofi S.A, Acuitas
Therapeutics, Antisense Therapeutics Ltd.
Click Here To Get A Sample Report
4
Table Of Content
  • 1. Executive Summary
  • 2. Report Structure
  • 3. Antisense RNAi Therapeutics Market
    Characteristics
  • 4. Antisense RNAi Therapeutics Market Product
    Analysis
  • 5. Antisense RNAi Therapeutics Market Supply
    Chain
  • 26. Key Mergers And Acquisitions In The Antisense
    RNAi Therapeutics Market
  • 27. Antisense RNAi Therapeutics Market Trends
    And Strategies
  • 28. Antisense RNAi Therapeutics Market Future
    Outlook and Potential Analysis
  • 29. Appendix
  • Click Here To Get A Sample Report

5
Get In Touch
Whatever your need be, at The Business Research
Company we provide research consulting solutions
for businesses, government agencies
consultancies, and market research companies.
6
Europe The Business Research Company 47
Anchorage Point, 42 Cuba Street, Canary Wharf,
London, England, E14 8NE. 44 207 1930
708 Email info_at_tbrc.info www.tbrc.info
Asia The Business Research Company, Horizon
Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara
Hills Hyderabad (India) 500033 91
8897263534 Email info_at_tbrc.info www.tbrc.info
Americas The Business Research Company 625 South
Avenue, Apt B204, Secane, Philadelphia, PA 19018,
USA 1 3156230293 Email info_at_tbrc.info www.tbrc.
info
About PowerShow.com